25 XP   0   0   10

Precigen Inc
Buy, Hold or Sell?

Let's analyze Precigen together

I guess you are interested in Precigen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Precigen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Precigen Inc

I send you an email if I find something interesting about Precigen Inc.

Quick analysis of Precigen (30 sec.)










What can you expect buying and holding a share of Precigen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
17.5%

What is your share worth?

Current worth
$0.38
Expected worth in 1 year
$0.04
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.34
Return On Investment
-23.3%

For what price can you sell your share?

Current Price per Share
$1.47
Expected price per share
$1.485 - $1.785
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Precigen (5 min.)




Live pricePrice per Share (EOD)

$1.47

Intrinsic Value Per Share

$-4.04 - $-2.54

Total Value Per Share

$-3.66 - $-2.15

2. Growth of Precigen (5 min.)




Is Precigen growing?

Current yearPrevious yearGrowGrow %
How rich?$97m$127.1m$2.9m2.3%

How much money is Precigen making?

Current yearPrevious yearGrowGrow %
Making money$2.5m-$19.6m$22.2m865.8%
Net Profit Margin-1,387.0%-856.7%--

How much money comes from the company's main activities?

3. Financial Health of Precigen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#365 / 966

Most Revenue
#331 / 966

Most Profit
#105 / 966

Most Efficient
#754 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Precigen? (5 min.)

Welcome investor! Precigen's management wants to use your money to grow the business. In return you get a share of Precigen.

What can you expect buying and holding a share of Precigen?

First you should know what it really means to hold a share of Precigen. And how you can make/lose money.

Speculation

The Price per Share of Precigen is $1.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Precigen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Precigen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.38. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Precigen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-6.4%0.010.7%0.021.7%-0.10-6.9%-0.15-10.5%
Usd Book Value Change Per Share-0.05-3.3%-0.09-5.9%0.117.4%-0.05-3.2%-0.03-2.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.021.1%
Usd Total Gains Per Share-0.05-3.3%-0.09-5.8%0.117.4%-0.05-3.2%-0.02-1.1%
Usd Price Per Share1.45-1.34-1.51-3.83-13.69-
Price to Earnings Ratio-3.85--2.24--2.63--7.36--14.68-
Price-to-Total Gains Ratio-29.56--18.65--7.85-2.55--68.28-
Price to Book Ratio3.77-2.76-3.58-9.62-10.26-
Price-to-Total Gains Ratio-29.56--18.65--7.85-2.55--68.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.47
Number of shares680
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.09-0.05
Usd Total Gains Per Share-0.09-0.05
Gains per Quarter (680 shares)-58.20-31.94
Gains per Year (680 shares)-232.81-127.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12-235-2430-128-138
24-469-4761-256-266
36-704-7091-384-394
47-939-9421-513-522
59-1173-11752-641-650
611-1408-14082-769-778
713-1643-16413-897-906
815-1877-18743-1025-1034
917-2112-21073-1153-1162
1019-2347-23404-1281-1290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%4.036.00.010.0%6.043.00.012.2%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%11.029.00.027.5%14.032.03.028.6%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.019.05.0%7.00.033.017.5%8.00.041.016.3%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%13.027.00.032.5%16.030.03.032.7%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Precigen

About Precigen Inc

Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients; AdenoVerse immunotherapy, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and ActoBiotics for specific disease modification. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV-associated cancer; and PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis, as well as AG019, which is based on the ActoBiotics platform and in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.

Fundamental data was last updated by Penke on 2024-06-19 03:49:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Precigen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Precigen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Net Profit Margin of -2,228.9% means that $-22.29 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Precigen Inc:

  • The MRQ is -2,228.9%. The company is making a huge loss. -2
  • The TTM is -1,387.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,228.9%TTM-1,387.0%-841.9%
TTM-1,387.0%YOY-856.7%-530.3%
TTM-1,387.0%5Y-570.7%-816.4%
5Y-570.7%10Y-357.0%-213.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,228.9%-168.0%-2,060.9%
TTM-1,387.0%-209.9%-1,177.1%
YOY-856.7%-242.3%-614.4%
5Y-570.7%-401.7%-169.0%
10Y-357.0%-532.2%+175.2%
1.1.2. Return on Assets

Shows how efficient Precigen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • -17.6% Return on Assets means that Precigen generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Precigen Inc:

  • The MRQ is -17.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.6%TTM-0.9%-16.7%
TTM-0.9%YOY-7.7%+6.8%
TTM-0.9%5Y-8.2%+7.3%
5Y-8.2%10Y-7.4%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.6%-11.9%-5.7%
TTM-0.9%-11.9%+11.0%
YOY-7.7%-11.3%+3.6%
5Y-8.2%-13.5%+5.3%
10Y-7.4%-14.9%+7.5%
1.1.3. Return on Equity

Shows how efficient Precigen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • -24.5% Return on Equity means Precigen generated $-0.24 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Precigen Inc:

  • The MRQ is -24.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.5%TTM-1.4%-23.1%
TTM-1.4%YOY-20.5%+19.2%
TTM-1.4%5Y-36.0%+34.6%
5Y-36.0%10Y-23.8%-12.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.5%-14.2%-10.3%
TTM-1.4%-15.7%+14.3%
YOY-20.5%-14.3%-6.2%
5Y-36.0%-19.2%-16.8%
10Y-23.8%-19.7%-4.1%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Precigen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Precigen is operating .

  • Measures how much profit Precigen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • An Operating Margin of -2,292.3% means the company generated $-22.92  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Precigen Inc:

  • The MRQ is -2,292.3%. The company is operating very inefficient. -2
  • The TTM is -1,349.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,292.3%TTM-1,349.6%-942.7%
TTM-1,349.6%YOY-839.6%-510.0%
TTM-1,349.6%5Y-512.3%-837.3%
5Y-512.3%10Y-321.0%-191.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,292.3%-354.6%-1,937.7%
TTM-1,349.6%-225.9%-1,123.7%
YOY-839.6%-252.2%-587.4%
5Y-512.3%-428.3%-84.0%
10Y-321.0%-531.1%+210.1%
1.2.2. Operating Ratio

Measures how efficient Precigen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 23.92 means that the operating costs are $23.92 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Precigen Inc:

  • The MRQ is 23.923. The company is inefficient in keeping operating costs low. -1
  • The TTM is 14.617. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ23.923TTM14.617+9.306
TTM14.617YOY9.396+5.221
TTM14.6175Y6.101+8.516
5Y6.10110Y4.175+1.926
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.9233.004+20.919
TTM14.6173.332+11.285
YOY9.3963.502+5.894
5Y6.1015.271+0.830
10Y4.1756.915-2.740
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Precigen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Precigen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.72 means the company has $1.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Precigen Inc:

  • The MRQ is 1.722. The company is able to pay all its short-term debts. +1
  • The TTM is 2.744. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.722TTM2.744-1.022
TTM2.744YOY2.877-0.133
TTM2.7445Y3.535-0.791
5Y3.53510Y3.597-0.063
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7223.767-2.045
TTM2.7444.000-1.256
YOY2.8774.905-2.028
5Y3.5355.883-2.348
10Y3.5976.286-2.689
1.3.2. Quick Ratio

Measures if Precigen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Quick Ratio of 2.54 means the company can pay off $2.54 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Precigen Inc:

  • The MRQ is 2.544. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.510. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.544TTM4.510-1.966
TTM4.510YOY3.430+1.080
TTM4.5105Y4.772-0.262
5Y4.77210Y4.723+0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5443.054-0.510
TTM4.5103.506+1.004
YOY3.4304.756-1.326
5Y4.7725.757-0.985
10Y4.7236.338-1.615
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Precigen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Precigen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Precigen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.28 means that Precigen assets are financed with 28.1% credit (debt) and the remaining percentage (100% - 28.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Precigen Inc:

  • The MRQ is 0.281. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.245. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.281TTM0.245+0.035
TTM0.245YOY0.483-0.237
TTM0.2455Y0.576-0.331
5Y0.57610Y0.464+0.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2810.330-0.049
TTM0.2450.342-0.097
YOY0.4830.287+0.196
5Y0.5760.368+0.208
10Y0.4640.382+0.082
1.4.2. Debt to Equity Ratio

Measures if Precigen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Precigen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 39.0% means that company has $0.39 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Precigen Inc:

  • The MRQ is 0.390. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.320. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.390TTM0.320+0.070
TTM0.320YOY1.653-1.333
TTM0.3205Y2.262-1.941
5Y2.26210Y1.426+0.836
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3900.365+0.025
TTM0.3200.415-0.095
YOY1.6530.370+1.283
5Y2.2620.443+1.819
10Y1.4260.476+0.950
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Precigen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Precigen generates.

  • Above 15 is considered overpriced but always compare Precigen to the Biotechnology industry mean.
  • A PE ratio of -3.85 means the investor is paying $-3.85 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Precigen Inc:

  • The EOD is -3.908. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.855. Based on the earnings, the company is expensive. -2
  • The TTM is -2.240. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.908MRQ-3.855-0.053
MRQ-3.855TTM-2.240-1.615
TTM-2.240YOY-2.633+0.393
TTM-2.2405Y-7.362+5.122
5Y-7.36210Y-14.681+7.319
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.908-2.341-1.567
MRQ-3.855-2.997-0.858
TTM-2.240-2.882+0.642
YOY-2.633-3.553+0.920
5Y-7.362-6.262-1.100
10Y-14.681-6.288-8.393
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Precigen Inc:

  • The EOD is -5.030. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.962. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.940. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.030MRQ-4.962-0.068
MRQ-4.962TTM-4.940-0.021
TTM-4.940YOY-6.182+1.241
TTM-4.9405Y-12.779+7.838
5Y-12.77910Y-36.489+23.710
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.030-2.932-2.098
MRQ-4.962-3.739-1.223
TTM-4.940-3.776-1.164
YOY-6.182-4.917-1.265
5Y-12.779-7.942-4.837
10Y-36.489-8.503-27.986
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Precigen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.77 means the investor is paying $3.77 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Precigen Inc:

  • The EOD is 3.825. Based on the equity, the company is fair priced.
  • The MRQ is 3.773. Based on the equity, the company is fair priced.
  • The TTM is 2.760. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.825MRQ3.773+0.052
MRQ3.773TTM2.760+1.013
TTM2.760YOY3.581-0.822
TTM2.7605Y9.620-6.860
5Y9.62010Y10.263-0.643
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.8251.843+1.982
MRQ3.7732.249+1.524
TTM2.7602.301+0.459
YOY3.5812.412+1.169
5Y9.6203.782+5.838
10Y10.2634.212+6.051
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Precigen Inc.

3.1. Institutions holding Precigen Inc

Institutions are holding 61.681% of the shares of Precigen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Patient Capital Management, LLC6.91451.23191745345514697559.1953
2024-03-31BlackRock Inc4.10550.000410363128-756992-6.8074
2024-03-31Vanguard Group Inc2.68130.00026768234198750.2945
2024-03-31Geode Capital Management, LLC1.20070.0004303088595880.3173
2024-03-31State Street Corporation1.11930.000228254501409175.2492
2024-03-31Iridian Asset Management LLC0.82850.5952091274863404.3064
2024-03-31D. E. Shaw & Co LP0.70710.002217848861131194173.0469
2024-03-31Millennium Management LLC0.54290.00091370451-1475460-51.8449
2024-03-31JPMorgan Chase & Co0.51290.00021294704-48572-3.6159
2024-03-31Northern Trust Corp0.42880.00031082317-135-0.0125
2024-03-31Charles Schwab Investment Management Inc0.42330.00041068527591095.8558
2024-03-31Morgan Stanley - Brokerage Accounts0.42130.00011063328-200981-15.8965
2024-03-31Renaissance Technologies Corp0.41680.0024105219017788720.3462
2024-03-31Opaleye Management Inc0.37540.2994947500-65000-6.4198
2024-03-31SMH Capital Inc.0.27930.18777050007050000
2024-03-31Nuveen Asset Management, LLC0.21190.000253498300
2024-03-31EMFO, LLC0.20580.689451947500
2024-03-31Clarivest Asset Management LLC0.18950.07194784008950.1874
2024-03-31Bank of New York Mellon Corp0.15950.0001402487-43914-9.8373
2024-03-31MSD Partners, L.P.0.14060.041335500000
Total 21.86493.124655191674+1209506+2.2%

3.2. Funds holding Precigen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Patient Opportunity C5.54631.20671400000010000007.6923
2024-04-30Vanguard Total Stock Mkt Idx Inv1.58360.0003399736700
2024-05-30iShares Russell 2000 ETF1.23770.0073124218237600.7663
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.75710.0026191109800
2024-03-31Fidelity Small Cap Index0.51860.00711308973-70998-5.1449
2024-05-30iShares Russell 2000 Value ETF0.46180.01331165578-1544-0.1323
2024-04-30JPM Thematics Genetic Thrps C2 Acc USD0.43740.24381104203-80535-6.7977
2024-05-30iShares Biotechnology ETF0.34910.0166881137-3332-0.3767
2024-04-30State St Russell Sm/Mid Cp® Indx NL Cl C0.34080.002886020800
2024-04-30Fidelity Extended Market Index0.2960.0027747042-6770-0.8981
2024-05-31Schwab US Small-Cap ETF™0.24320.004961397400
2024-04-30Vanguard Russell 2000 ETF0.1930.006848724816800.346
2024-05-31State St Russell Sm Cap® Indx SL Cl I0.18250.006946058800
2024-03-31Acuitas US Microcap Strategy0.15550.144339250000
2023-09-30BlackRock Extended Mkt Composite0.15220.003938408523640.6193
2023-12-31NT R2000 Value Index Fund - NL0.150.0134378742-20492-5.1328
2024-03-31NT R2000 Index Fund - NL0.14570.0071367850-8207-2.1824
2024-03-31BlackRock Extended Equity Market K0.13140.00333317211190.0359
2024-04-30Schwab Small Cap Index0.12270.0072309642203447.0322
2024-03-31Nuveen Equity Index R60.11630.00129361900
Total 13.12091.701733119793+856389+2.6%

3.3. Insider Transactions

Insiders are holding 11.48% of the shares of Precigen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-28Randal J KirkBUY966861.41
2023-09-22Dean J MitchellBUY250001.41
2023-08-25Helen SabzevariSELL769691.53
2023-08-24Donald P LehrSELL109471.64
2023-08-24Harry Jr. ThomasianSELL90451.64
2023-08-24Jeffrey Thomas PerezSELL88911.64
2023-08-24Rutul R ShahSELL53881.64
2023-08-18Helen SabzevariSELL558551.66
2023-08-17Donald P LehrSELL107621.55
2023-08-17Harry Jr. ThomasianSELL88931.55
2023-08-17Jeffrey Thomas PerezSELL87411.55
2023-08-17Rutul R ShahSELL52981.55
2023-08-16Randal J KirkBUY1194111.51
2023-08-14Steven FrankBUY4000001.72
2023-08-11Helen SabzevariSELL414361.44
2023-08-10Donald P LehrSELL110261.21
2023-08-10Harry Jr. ThomasianSELL68521.21
2023-08-10Jeffrey Thomas PerezSELL89561.21
2023-08-10Rutul R ShahSELL54291.21
2023-08-04Helen SabzevariSELL528701.1
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Precigen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.049-0.086+76%0.109-145%-0.047-4%-0.033-32%
Book Value Per Share--0.3840.515-25%0.504-24%0.499-23%1.325-71%
Current Ratio--1.7222.744-37%2.877-40%3.535-51%3.597-52%
Debt To Asset Ratio--0.2810.245+14%0.483-42%0.576-51%0.464-40%
Debt To Equity Ratio--0.3900.320+22%1.653-76%2.262-83%1.426-73%
Dividend Per Share---0.001-100%-0%0.000-100%0.017-100%
Eps---0.0940.010-1025%0.025-482%-0.101+7%-0.154+64%
Free Cash Flow Per Share---0.073-0.068-7%-0.067-8%-0.084+15%-0.088+21%
Free Cash Flow To Equity Per Share---0.073-0.082+13%-0.177+143%-0.078+7%-0.020-73%
Gross Profit Margin--1.0001.0000%1.0000%1.005-1%1.0030%
Intrinsic Value_10Y_max---2.538--------
Intrinsic Value_10Y_min---4.040--------
Intrinsic Value_1Y_max---0.266--------
Intrinsic Value_1Y_min---0.365--------
Intrinsic Value_3Y_max---0.790--------
Intrinsic Value_3Y_min---1.137--------
Intrinsic Value_5Y_max---1.304--------
Intrinsic Value_5Y_min---1.948--------
Market Cap371057400.000+1%366009000.000338242800.000+8%381154200.000-4%966389970.000-62%3454872540.000-89%
Net Profit Margin---22.289-13.870-38%-8.567-62%-5.707-74%-3.570-84%
Operating Margin---22.923-13.496-41%-8.396-63%-5.123-78%-3.210-86%
Operating Ratio--23.92314.617+64%9.396+155%6.101+292%4.175+473%
Pb Ratio3.825+1%3.7732.760+37%3.581+5%9.620-61%10.263-63%
Pe Ratio-3.908-1%-3.855-2.240-42%-2.633-32%-7.362+91%-14.681+281%
Price Per Share1.470+1%1.4501.340+8%1.510-4%3.829-62%13.687-89%
Price To Free Cash Flow Ratio-5.030-1%-4.962-4.9400%-6.182+25%-12.779+158%-36.489+635%
Price To Total Gains Ratio-29.972-1%-29.565-18.647-37%-7.849-73%2.553-1258%-68.280+131%
Quick Ratio--2.5444.510-44%3.430-26%4.772-47%4.723-46%
Return On Assets---0.176-0.009-95%-0.077-56%-0.082-53%-0.074-58%
Return On Equity---0.245-0.014-94%-0.205-16%-0.360+47%-0.238-3%
Total Gains Per Share---0.049-0.086+75%0.109-145%-0.047-4%-0.017-66%
Usd Book Value--97019000.000130076500.000-25%127144250.000-24%125857850.000-23%334477650.000-71%
Usd Book Value Change Per Share---0.049-0.086+76%0.109-145%-0.047-4%-0.033-32%
Usd Book Value Per Share--0.3840.515-25%0.504-24%0.499-23%1.325-71%
Usd Dividend Per Share---0.001-100%-0%0.000-100%0.017-100%
Usd Eps---0.0940.010-1025%0.025-482%-0.101+7%-0.154+64%
Usd Free Cash Flow---18441000.000-17091249.750-7%-17037250.000-8%-21174749.950+15%-22307349.975+21%
Usd Free Cash Flow Per Share---0.073-0.068-7%-0.067-8%-0.084+15%-0.088+21%
Usd Free Cash Flow To Equity Per Share---0.073-0.082+13%-0.177+143%-0.078+7%-0.020-73%
Usd Market Cap371057400.000+1%366009000.000338242800.000+8%381154200.000-4%966389970.000-62%3454872540.000-89%
Usd Price Per Share1.470+1%1.4501.340+8%1.510-4%3.829-62%13.687-89%
Usd Profit---23738000.0002566500.250-1025%-19653250.000-17%-30594999.950+29%-41295699.975+74%
Usd Revenue--1065000.0005195500.000-80%5811750.000-82%17956600.000-94%30176225.000-96%
Usd Total Gains Per Share---0.049-0.086+75%0.109-145%-0.047-4%-0.017-66%
 EOD+5 -3MRQTTM+11 -24YOY+6 -275Y+13 -2310Y+11 -25

4.2. Fundamental Score

Let's check the fundamental score of Precigen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.908
Price to Book Ratio (EOD)Between0-13.825
Net Profit Margin (MRQ)Greater than0-22.289
Operating Margin (MRQ)Greater than0-22.923
Quick Ratio (MRQ)Greater than12.544
Current Ratio (MRQ)Greater than11.722
Debt to Asset Ratio (MRQ)Less than10.281
Debt to Equity Ratio (MRQ)Less than10.390
Return on Equity (MRQ)Greater than0.15-0.245
Return on Assets (MRQ)Greater than0.05-0.176
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Precigen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.698
Ma 20Greater thanMa 501.606
Ma 50Greater thanMa 1001.476
Ma 100Greater thanMa 2001.467
OpenGreater thanClose1.510
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets134,847
Total Liabilities37,828
Total Stockholder Equity97,019
 As reported
Total Liabilities 37,828
Total Stockholder Equity+ 97,019
Total Assets = 134,847

Assets

Total Assets134,847
Total Current Assets49,546
Long-term Assets85,301
Total Current Assets
Cash And Cash Equivalents 17,478
Short-term Investments 27,280
Net Receivables 1,162
Other Current Assets 3,626
Total Current Assets  (as reported)49,546
Total Current Assets  (calculated)49,546
+/-0
Long-term Assets
Property Plant Equipment 19,278
Goodwill 26,555
Intangible Assets 38,717
Long-term Assets  (as reported)85,301
Long-term Assets  (calculated)84,550
+/- 751

Liabilities & Shareholders' Equity

Total Current Liabilities28,774
Long-term Liabilities9,054
Total Stockholder Equity97,019
Total Current Liabilities
Short-term Debt 1,318
Accounts payable 4,716
Other Current Liabilities 22,333
Total Current Liabilities  (as reported)28,774
Total Current Liabilities  (calculated)28,367
+/- 407
Long-term Liabilities
Capital Lease Obligations 6,705
Long-term Liabilities  (as reported)9,054
Long-term Liabilities  (calculated)6,705
+/- 2,349
Total Stockholder Equity
Retained Earnings -1,988,209
Accumulated Other Comprehensive Income -2,797
Other Stockholders Equity 2,088,025
Total Stockholder Equity (as reported)97,019
Total Stockholder Equity (calculated)97,019
+/-0
Other
Cash and Short Term Investments 44,758
Common Stock Shares Outstanding 249,220
Current Deferred Revenue407
Liabilities and Stockholders Equity 134,847
Net Debt -10,773
Net Invested Capital 97,019
Net Working Capital 20,772
Property Plant and Equipment Gross 43,774
Short Long Term Debt Total 6,705



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-31
> Total Assets 
0
0
0
151,646
199,685
283,451
474,198
469,472
547,808
500,537
538,500
576,272
819,987
792,939
989,887
982,046
962,428
1,031,112
1,005,588
949,068
915,928
933,986
898,261
846,851
895,666
825,151
980,415
716,177
709,864
655,188
604,905
455,763
404,672
361,715
336,186
314,587
406,984
402,573
376,899
359,856
335,568
321,224
259,245
215,977
241,546
207,527
190,688
151,043
134,847
134,847151,043190,688207,527241,546215,977259,245321,224335,568359,856376,899402,573406,984314,587336,186361,715404,672455,763604,905655,188709,864716,177980,415825,151895,666846,851898,261933,986915,928949,0681,005,5881,031,112962,428982,046989,887792,939819,987576,272538,500500,537547,808469,472474,198283,451199,685151,646000
   > Total Current Assets 
0
0
0
13,533
66,014
134,318
206,235
187,556
232,932
188,303
181,304
174,773
238,799
359,538
302,431
323,801
336,539
345,657
316,223
315,181
281,670
234,117
179,740
154,047
187,545
147,814
310,470
285,483
232,175
183,164
157,332
234,643
189,383
172,995
151,116
148,948
144,118
156,685
153,092
156,628
154,937
164,619
162,806
118,159
137,743
105,632
92,988
68,755
49,546
49,54668,75592,988105,632137,743118,159162,806164,619154,937156,628153,092156,685144,118148,948151,116172,995189,383234,643157,332183,164232,175285,483310,470147,814187,545154,047179,740234,117281,670315,181316,223345,657336,539323,801302,431359,538238,799174,773181,304188,303232,932187,556206,235134,31866,01413,533000
       Cash And Cash Equivalents 
0
0
0
10,403
59,724
34,461
61,222
49,509
110,052
74,505
24,704
27,466
99,015
98,899
125,433
135,782
145,733
155,081
69,707
62,607
69,852
64,360
64,216
68,111
119,930
78,471
82,417
102,768
106,544
58,162
44,428
65,793
37,840
46,713
27,740
51,792
27,355
36,412
41,728
42,920
40,321
43,844
9,067
4,858
9,740
16,546
10,076
7,578
17,478
17,4787,57810,07616,5469,7404,8589,06743,84440,32142,92041,72836,41227,35551,79227,74046,71337,84065,79344,42858,162106,544102,76882,41778,471119,93068,11164,21664,36069,85262,60769,707155,081145,733135,782125,43398,89999,01527,46624,70474,505110,05249,50961,22234,46159,72410,403000
       Short-term Investments 
0
0
0
260
274
95,454
136,672
127,980
112,755
101,046
98,380
88,495
82,461
67,431
90,864
102,528
114,659
115,667
166,839
174,602
135,377
92,804
44,502
11,558
3,573
2,658
164,876
120,072
75,277
67,641
61,605
9,260
111,332
86,292
85,358
48,325
78,331
78,694
72,684
72,240
71,821
71,453
62,260
51,092
94,351
71,888
63,679
55,277
27,280
27,28055,27763,67971,88894,35151,09262,26071,45371,82172,24072,68478,69478,33148,32585,35886,292111,3329,26061,60567,64175,277120,072164,8762,6583,57311,55844,50292,804135,377174,602166,839115,667114,659102,52890,86467,43182,46188,49598,380101,046112,755127,980136,67295,454274260000
       Net Receivables 
0
0
0
707
3,761
1,305
5,349
7,357
7,419
9,808
37,568
29,264
27,079
160,730
55,866
52,294
44,600
43,716
42,219
42,485
43,201
43,637
38,253
39,841
30,719
33,822
30,307
28,078
24,881
34,457
24,971
26,228
19,979
23,995
19,360
20,427
21,357
26,671
21,083
21,471
24,866
1,871
2,454
13,804
15,522
14,406
14,105
1,575
1,162
1,1621,57514,10514,40615,52213,8042,4541,87124,86621,47121,08326,67121,35720,42719,36023,99519,97926,22824,97134,45724,88128,07830,30733,82230,71939,84138,25343,63743,20142,48542,21943,71644,60052,29455,866160,73027,07929,26437,5689,8087,4197,3575,3491,3053,761707000
       Other Current Assets 
0
0
0
2,163
2,255
3,098
2,992
2,710
2,706
2,944
3,978
3,759
4,073
5,477
7,930
6,634
6,469
6,701
8,591
7,361
7,170
7,183
8,052
7,057
6,065
5,803
7,589
6,131
5,577
4,712
9,033
6,444
5,596
3,266
8,310
7,192
6,430
3,484
7,661
6,736
5,199
2,654
6,363
4,779
4,330
2,792
5,128
4,325
3,626
3,6264,3255,1282,7924,3304,7796,3632,6545,1996,7367,6613,4846,4307,1928,3103,2665,5966,4449,0334,7125,5776,1317,5895,8036,0657,0578,0527,1837,1707,3618,5916,7016,4696,6347,9305,4774,0733,7593,9782,9442,7062,7102,9923,0982,2552,163000
   > Long-term Assets 
0
0
0
138,113
133,671
149,133
267,963
281,916
314,876
312,234
357,196
401,499
581,188
433,401
687,456
658,245
625,889
685,455
689,365
633,887
634,258
699,869
718,521
692,804
708,121
677,337
669,945
430,694
477,689
472,024
447,573
221,120
215,289
188,720
185,070
165,639
262,866
245,888
223,807
203,228
180,631
156,605
96,439
97,818
103,803
101,895
97,700
82,288
85,301
85,30182,28897,700101,895103,80397,81896,439156,605180,631203,228223,807245,888262,866165,639185,070188,720215,289221,120447,573472,024477,689430,694669,945677,337708,121692,804718,521699,869634,258633,887689,365685,455625,889658,245687,456433,401581,188401,499357,196312,234314,876281,916267,963149,133133,671138,113000
       Property Plant Equipment 
0
0
0
18,687
18,939
18,410
17,020
16,629
18,116
17,389
35,596
38,000
38,015
40,863
42,201
42,739
44,673
46,659
54,429
64,672
61,233
84,222
93,335
112,674
107,044
103,411
107,245
128,874
162,777
161,959
144,322
86,197
83,663
62,052
63,981
44,277
41,443
44,071
43,554
45,215
43,593
16,621
16,322
15,292
14,525
14,059
14,179
14,208
19,278
19,27814,20814,17914,05914,52515,29216,32216,62143,59345,21543,55444,07141,44344,27763,98162,05283,66386,197144,322161,959162,777128,874107,245103,411107,044112,67493,33584,22261,23364,67254,42946,65944,67342,73942,20140,86338,01538,00035,59617,38918,11616,62917,02018,41018,93918,687000
       Goodwill 
0
0
0
0
13,846
13,846
13,846
13,823
39,689
34,865
98,778
101,059
104,045
118,965
166,866
165,169
164,575
161,257
159,793
157,175
157,825
164,931
166,821
153,289
154,748
151,666
151,276
149,585
150,755
149,916
147,949
63,754
63,703
54,122
54,237
54,363
54,238
54,273
54,206
54,148
53,613
36,864
36,713
36,923
36,966
36,966
36,894
26,612
26,555
26,55526,61236,89436,96636,96636,92336,71336,86453,61354,14854,20654,27354,23854,36354,23754,12263,70363,754147,949149,916150,755149,585151,276151,666154,748153,289166,821164,931157,825157,175159,793161,257164,575165,169166,866118,965104,045101,05998,77834,86539,68913,82313,84613,84613,8460000
       Long Term Investments 
0
0
0
0
0
0
0
0
40,212
73,545
149,194
195,222
0
101,896
212,889
199,077
136,906
89,483
0
53,170
21,476
23,901
26,642
28,685
10,745
9,624
0
18,859
19,229
39,596
24,002
1,461
1,108
859
337
0
103,610
85,269
66,926
48,562
29,914
11,877
0
0
7,460
7,127
5,271
0
0
005,2717,1277,4600011,87729,91448,56266,92685,269103,61003378591,1081,46124,00239,59619,22918,85909,62410,74528,68526,64223,90121,47653,170089,483136,906199,077212,889101,8960195,222149,19473,54540,21200000000
       Intangible Assets 
0
0
0
29,506
43,681
42,972
42,263
41,956
41,269
45,406
68,216
65,947
129,308
162,234
256,284
247,535
255,460
244,314
238,581
225,615
223,074
240,360
240,897
232,877
231,883
218,838
213,244
129,291
125,868
112,526
107,141
68,346
65,489
64,759
65,018
65,396
61,230
59,942
56,914
54,115
51,427
45,933
42,416
44,455
43,848
42,656
40,426
40,701
38,717
38,71740,70140,42642,65643,84844,45542,41645,93351,42754,11556,91459,94261,23065,39665,01864,75965,48968,346107,141112,526125,868129,291213,244218,838231,883232,877240,897240,360223,074225,615238,581244,314255,460247,535256,284162,234129,30865,94768,21645,40641,26941,95642,26342,97243,68129,506000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,976
2,381
7,652
1,921
1,362
1,326
1,341
1,497
10,956
1,433
1,332
1,239
1,188
1,131
45,261
871
1,025
0
949
0
0
0
00094901,02587145,2611,1311,1881,2391,3321,43310,9561,4971,3411,3261,3621,9217,6522,3811,976000000000000000000000000000
> Total Liabilities 
0
0
0
473,199
71,941
644,975
82,990
88,129
115,910
112,171
158,658
166,983
166,642
306,012
260,264
277,160
287,596
402,931
397,168
379,820
365,767
362,436
345,082
300,306
324,240
258,010
424,972
337,455
375,041
375,965
376,484
384,052
317,443
312,173
277,634
247,413
232,189
243,377
245,652
252,508
261,732
265,571
116,713
89,718
57,413
41,317
43,010
41,644
37,828
37,82841,64443,01041,31757,41389,718116,713265,571261,732252,508245,652243,377232,189247,413277,634312,173317,443384,052376,484375,965375,041337,455424,972258,010324,240300,306345,082362,436365,767379,820397,168402,931287,596277,160260,264306,012166,642166,983158,658112,171115,91088,12982,990644,97571,941473,199000
   > Total Current Liabilities 
0
0
0
16,717
17,503
17,511
19,717
19,829
22,212
20,692
39,263
47,482
48,703
122,807
77,093
75,904
77,937
95,499
100,521
94,605
90,650
95,686
87,796
80,173
86,854
83,245
92,330
61,562
59,422
51,633
81,955
122,912
70,637
64,100
30,661
42,127
25,243
28,869
28,989
34,645
25,601
29,901
104,864
78,645
46,733
30,773
32,875
22,985
28,774
28,77422,98532,87530,77346,73378,645104,86429,90125,60134,64528,98928,86925,24342,12730,66164,10070,637122,91281,95551,63359,42261,56292,33083,24586,85480,17387,79695,68690,65094,605100,52195,49977,93775,90477,093122,80748,70347,48239,26320,69222,21219,82919,71717,51117,50316,717000
       Short-term Debt 
0
0
0
49
89
255
244
30
0
0
2,046
3,948
2,047
2,300
1,789
1,491
1,429
952
1,020
1,206
798
719
673
735
822
1,063
746
1,025
5,619
5,668
38,226
37,774
37,399
36,622
5,005
3,017
3,017
2,293
2,314
1,953
1,945
1,033
83,110
44,428
15,063
1,421
1,200
1,202
1,318
1,3181,2021,2001,42115,06344,42883,1101,0331,9451,9532,3142,2933,0173,0175,00536,62237,39937,77438,2265,6685,6191,0257461,0638227356737197981,2061,0209521,4291,4911,7892,3002,0473,9482,04600302442558949000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
559
841
855
32,002
33,592
33,091
32,108
421
360
359
356
355
402
355
0
82,069
43,219
13,819
0
0
0
0
000013,81943,21982,069035540235535635936042132,10833,09133,59232,002855841559000000000000000000000000000
       Accounts payable 
0
0
0
632
704
1,486
949
1,057
1,973
1,799
3,575
6,267
6,904
7,322
4,546
4,967
7,537
8,204
7,866
8,478
7,950
8,221
7,852
8,701
7,842
8,444
8,522
13,420
12,601
8,563
7,395
5,917
4,777
3,650
4,233
4,598
4,295
4,937
3,624
5,405
4,415
2,668
4,201
4,068
3,809
2,510
2,351
1,726
4,716
4,7161,7262,3512,5103,8094,0684,2012,6684,4155,4053,6244,9374,2954,5984,2333,6504,7775,9177,3958,56312,60113,4208,5228,4447,8428,7017,8528,2217,9508,4787,8668,2047,5374,9674,5467,3226,9046,2673,5751,7991,9731,0579491,486704632000
       Other Current Liabilities 
0
0
0
6,073
6,824
7,500
11,126
10,949
9,300
8,187
19,692
20,745
22,463
84,448
38,752
34,080
31,276
32,480
36,698
31,557
31,569
39,084
30,982
27,867
29,544
33,918
45,026
31,563
24,053
20,809
23,570
73,524
17,320
17,236
17,279
31,712
14,086
18,363
19,358
22,845
16,572
26,036
17,477
30,124
27,846
26,827
28,815
19,548
22,333
22,33319,54828,81526,82727,84630,12417,47726,03616,57222,84519,35818,36314,08631,71217,27917,23617,32073,52423,57020,80924,05331,56345,02633,91829,54427,86730,98239,08431,56931,55736,69832,48031,27634,08038,75284,44822,46320,74519,6928,1879,30010,94911,1267,5006,8246,073000
   > Long-term Liabilities 
0
0
0
456,482
54,438
627,464
63,273
68,300
93,698
91,479
119,395
119,501
117,939
183,205
183,171
201,256
209,659
307,432
296,647
285,215
275,117
266,750
257,286
220,133
237,386
174,765
332,642
275,893
315,619
324,332
294,529
261,140
246,806
248,073
246,973
205,286
206,946
214,508
216,663
217,863
236,131
235,670
11,849
11,073
10,680
10,544
10,135
18,659
9,054
9,05418,65910,13510,54410,68011,07311,849235,670236,131217,863216,663214,508206,946205,286246,973248,073246,806261,140294,529324,332315,619275,893332,642174,765237,386220,133257,286266,750275,117285,215296,647307,432209,659201,256183,171183,205117,939119,501119,39591,47993,69868,30063,273627,46454,438456,482000
       Long term Debt Total 
0
0
0
0
0
0
0
0
1,784
2,001
9,428
8,694
0
8,040
7,796
7,598
7,613
7,530
0
7,562
7,608
7,684
7,673
7,535
7,425
7,273
183,133
211,235
214,010
212,479
184,034
186,321
188,730
191,205
0
171,522
174,158
176,922
179,817
182,749
201,112
0
0
0
0
0
0
0
0
00000000201,112182,749179,817176,922174,158171,5220191,205188,730186,321184,034212,479214,010211,235183,1337,2737,4257,5357,6737,6847,6087,56207,5307,6137,5987,7968,04008,6949,4282,0011,78400000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
64,658
61,424
73,096
72,313
50,970
35,662
35,656
32,849
26,020
25,845
25,765
25,647
25,612
25,511
28,898
3,910
4,081
0
3,999
0
0
0
0003,99904,0813,91028,89825,51125,61225,64725,76525,84526,02032,84935,65635,66250,97072,31373,09661,42464,658000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
91,041
88,747
109,342
110,108
0
174,278
174,508
192,863
199,016
296,745
0
273,785
263,462
253,922
243,866
209,147
173,949
164,320
9,363
7,213
6,720
6,332
5,732
2,834
2,785
2,698
0
2,897
2,722
2,692
2,574
2,539
2,438
0
0
0
2,239
2,181
0
0
0
0002,1812,2390002,4382,5392,5742,6922,7222,89702,6982,7852,8345,7326,3326,7207,2139,363164,320173,949209,147243,866253,922263,462273,7850296,745199,016192,863174,508174,2780110,108109,34288,74791,04100000000
> Total Stockholder Equity
0
0
0
-321,553
112,666
-376,149
377,133
366,722
415,902
373,255
358,361
384,761
640,668
474,835
718,287
694,078
664,932
619,230
600,473
560,237
528,538
550,870
533,613
533,631
553,109
549,752
539,399
362,855
313,029
279,223
228,421
71,711
87,229
49,542
58,552
67,174
174,795
159,196
131,247
107,348
73,836
55,653
142,532
126,259
184,133
166,210
147,678
118,498
97,019
97,019118,498147,678166,210184,133126,259142,53255,65373,836107,348131,247159,196174,79567,17458,55249,54287,22971,711228,421279,223313,029362,855539,399549,752553,109533,631533,613550,870528,538560,237600,473619,230664,932694,078718,287474,835640,668384,761358,361373,255415,902366,722377,133-376,149112,666-321,553000
   Common Stock
0
0
0
0
0
-15,600
-490,501
386,611
0
0
0
0
0
0
0
0
0
0
0
580,071
0
0
0
580,071
0
0
0
-579
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000-579000580,071000580,07100000000000386,611-490,501-15,60000000
   Retained Earnings Total Equity000-1,911,620-1,891,301-1,868,567-1,846,391-1,933,770-1,916,135-1,915,556-1,890,522-1,860,758-1,840,708-1,823,3900-1,752,221-1,708,867-1,652,869-1,483,654-1,430,020-1,391,254-1,330,545-990,080-932,756-867,374-847,820-820,554-780,865-762,201-729,3410-656,222-607,158-542,729-510,015-471,8020-458,236-477,067-424,342-372,29900000000
   Accumulated Other Comprehensive Income 
0
0
0
-13,375
-9
14
28
52
144
81
98
-4
-3,137
-2,285
-5,195
-12,752
-11,435
-21,651
-25,302
-36,202
-32,967
-24,221
-16,750
-15,554
-9,587
-21,848
-22,900
-28,612
-28,325
-28,206
-33,102
-27,468
-1,354
-650
1,362
3,997
1,746
2,541
1,515
203
-1,699
-4,556
-7,181
-3,488
-2,699
-2,518
-3,561
-3,894
-2,797
-2,797-3,894-3,561-2,518-2,699-3,488-7,181-4,556-1,6992031,5152,5411,7463,9971,362-650-1,354-27,468-33,102-28,206-28,325-28,612-22,900-21,848-9,587-15,554-16,750-24,221-32,967-36,202-25,302-21,651-11,435-12,752-5,195-2,285-3,137-49881144522814-9-13,375000
   Capital Surplus 
0
0
0
0
0
0
0
0
788,057
797,516
835,330
843,001
0
948,922
1,233,497
1,249,559
1,283,525
1,297,103
0
1,325,780
1,323,706
1,355,956
1,370,917
1,397,005
1,492,916
1,504,356
1,552,379
1,722,012
1,732,608
1,737,449
1,745,177
1,752,048
1,797,450
1,802,413
0
1,886,567
2,013,757
2,017,413
2,020,254
2,022,701
1,991,670
1,993,979
1,996,104
1,998,314
2,078,133
2,080,348
0
0
0
0002,080,3482,078,1331,998,3141,996,1041,993,9791,991,6702,022,7012,020,2542,017,4132,013,7571,886,56701,802,4131,797,4501,752,0481,745,1771,737,4491,732,6081,722,0121,552,3791,504,3561,492,9161,397,0051,370,9171,355,9561,323,7061,325,78001,297,1031,283,5251,249,5591,233,497948,9220843,001835,330797,516788,05700000000
   Treasury Stock0000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
-393,284
476,146
-552,258
757,618
760,413
788,057
797,516
835,330
843,001
1,074,944
948,922
1,233,497
1,249,559
1,283,525
1,297,103
1,310,979
1,325,578
1,323,706
1,355,956
1,370,917
1,397,451
1,492,916
1,504,356
1,552,379
1,722,400
1,732,608
1,737,449
1,745,177
1,752,048
1,797,450
1,802,413
1,838,919
1,886,567
2,013,757
2,017,413
2,020,254
2,022,701
1,991,670
1,993,979
1,996,104
1,998,314
2,078,133
2,080,348
2,082,654
2,086,863
2,088,025
2,088,0252,086,8632,082,6542,080,3482,078,1331,998,3141,996,1041,993,9791,991,6702,022,7012,020,2542,017,4132,013,7571,886,5671,838,9191,802,4131,797,4501,752,0481,745,1771,737,4491,732,6081,722,4001,552,3791,504,3561,492,9161,397,4511,370,9171,355,9561,323,7061,325,5781,310,9791,297,1031,283,5251,249,5591,233,497948,9221,074,944843,001835,330797,516788,057760,413757,618-552,258476,146-393,284000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,225
Cost of Revenue-10,967
Gross Profit-4,742-4,742
 
Operating Income (+$)
Gross Profit-4,742
Operating Expense-84,181
Operating Income-88,923-88,923
 
Operating Expense (+$)
Research Development48,614
Selling General Administrative40,415
Selling And Marketing Expenses0
Operating Expense84,18189,029
 
Net Interest Income (+$)
Interest Income3,237
Interest Expense-468
Other Finance Cost-0
Net Interest Income2,769
 
Pretax Income (+$)
Operating Income-88,923
Net Interest Income2,769
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-96,362-81,484
EBIT - interestExpense = -89,391
-96,362
-95,436
Interest Expense468
Earnings Before Interest and Taxes (EBIT)-88,923-95,894
Earnings Before Interest and Taxes (EBITDA)-82,255
 
After tax Income (+$)
Income Before Tax-96,362
Tax Provision--458
Net Income From Continuing Ops-95,904-95,904
Net Income-95,904
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses95,148
Total Other Income/Expenses Net-7,439-2,769
 

Technical Analysis of Precigen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Precigen. The general trend of Precigen is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Precigen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Precigen Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.67 < 1.67 < 1.785.

The bearish price targets are: 1.49 > 1.49 > 1.485.

Tweet this
Precigen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Precigen Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Precigen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Precigen Inc. The current macd is 0.00706156.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Precigen price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Precigen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Precigen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Precigen Inc Daily Moving Average Convergence/Divergence (MACD) ChartPrecigen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Precigen Inc. The current adx is 21.44.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Precigen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Precigen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Precigen Inc. The current sar is 1.68213174.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Precigen Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Precigen Inc. The current rsi is 44.70. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Precigen Inc Daily Relative Strength Index (RSI) ChartPrecigen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Precigen Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Precigen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Precigen Inc Daily Stochastic Oscillator ChartPrecigen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Precigen Inc. The current cci is -134.24657534.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Precigen Inc Daily Commodity Channel Index (CCI) ChartPrecigen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Precigen Inc. The current cmo is -19.99068734.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Precigen Inc Daily Chande Momentum Oscillator (CMO) ChartPrecigen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Precigen Inc. The current willr is -90.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Precigen Inc Daily Williams %R ChartPrecigen Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Precigen Inc.

Precigen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Precigen Inc. The current atr is 0.09259746.

Precigen Inc Daily Average True Range (ATR) ChartPrecigen Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Precigen Inc. The current obv is 21,711,877.

Precigen Inc Daily On-Balance Volume (OBV) ChartPrecigen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Precigen Inc. The current mfi is 45.40.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Precigen Inc Daily Money Flow Index (MFI) ChartPrecigen Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Precigen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Precigen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Precigen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.698
Ma 20Greater thanMa 501.606
Ma 50Greater thanMa 1001.476
Ma 100Greater thanMa 2001.467
OpenGreater thanClose1.510
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Precigen with someone you think should read this too:
  • Are you bullish or bearish on Precigen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Precigen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Precigen Inc

I send you an email if I find something interesting about Precigen Inc.


Stay informed about Precigen Inc.

Receive notifications about Precigen Inc in your mailbox!